Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.

Mogashoa T, Melamu P, Derendinger B, Ley SD, Streicher EM, Iketleng T, Mupfumi L, Mokomane M, Kgwaadira B, Rankgoane-Pono G, Tsholofelo TT, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S.

Pathogens. 2019 Oct 28;8(4). pii: E208. doi: 10.3390/pathogens8040208.

2.

Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.

de Vos M, Ley SD, Wiggins KB, Derendinger B, Dippenaar A, Grobbelaar M, Reuter A, Dolby T, Burns S, Schito M, Engelthaler DM, Metcalfe J, Theron G, van Rie A, Posey J, Warren R, Cox H.

N Engl J Med. 2019 May 30;380(22):2178-2180. doi: 10.1056/NEJMc1815121. No abstract available.

3.

Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.

de Vos M, Derendinger B, Dolby T, Simpson J, van Helden PD, Rice JE, Wangh LJ, Theron G, Warren RM.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00531-18. doi: 10.1128/JCM.00531-18. Print 2018 Sep.

4.

Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping.

Venter R, Derendinger B, de Vos M, Pillay S, Dolby T, Simpson J, Kitchin N, Ruiters A, van Helden PD, Warren RM, Theron G.

Sci Rep. 2017 Nov 1;7(1):14854. doi: 10.1038/s41598-017-14385-x.

5.

Comparative diffusion of drugs through bronchial tissue.

van Zyl JM, Derendinger B, Seifart HI, Van der Bijl P.

Int J Pharm. 2008 Jun 5;357(1-2):32-6. doi: 10.1016/j.ijpharm.2008.01.028. Epub 2008 Jan 20.

PMID:
18295419

Supplemental Content

Loading ...
Support Center